Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 15/20 | 0.61 |
| ▸ | P2RY4 | P51582 | 9/20 | 0.61 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.61 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biotin SCHEMBL381578 | 0.90 | DUT (0.52) | P2RY2P2RY4P2RY6 | |
| SCHEMBL14204816 | 0.85 | P2RY2 (0.54) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL14204819 | 0.85 | P2RY6 (0.54) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL523981 | 0.83 | F2 (0.47) | P2RY2P2RY4P2RY6 | |
| Uridine Triphosphate SCHEMBL24414746 | 0.81 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL2778525 | 0.81 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL376210 | 0.81 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL14406726 | 0.81 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL12671699 | 0.81 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL76682 | 0.81 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160015743-A1 | METHODS FOR TREATING CANCER | RUSH UNIVERSITY MEDICAL CENTER (US) | 2016-01-21 | — | — | US | disclosed |
| US-9102942-B2 | Pharmaceutical composition for inhibiting abnormal proliferation of cells | EWHA University—Industry Collaboration Foundation (KR) | 2015-08-11 | — | — | US | disclosed |
| US-20120308568-A1 | PHARMACEUTICAL COMPOSITION FOR INHIBITING ABNORMAL PROLIFERATION OF CELLS | EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUNDATION (KR) | 2012-12-06 | — | — | US | disclosed |
| WO-2011096756-A9 | PHARMACEUTICAL COMPOSITION FOR INHIBITING ABNORMAL PROLIFERATION OF CELLS | 이화여자대학교 산학협력단 (KR) | 2012-03-08 | — | — | WO | disclosed |
| WO-2011096756-A2 | PHARMACEUTICAL COMPOSITION FOR INHIBITING ABNORMAL PROLIFERATION OF CELLS | 이화여자대학교 산학협력단 (KR) | 2011-08-11 | — | — | WO | disclosed |